Powered by
RepliCel Life Sciences in 6th consecutive fall, nears three-month low March 01, 2017 17:00 EST
Mar 1, 2017 - News Bites Canadian Markets

CANADIAN DAILY STOCK REPORT

RepliCel Life Sciences Inc. (TSXV:RP), Canada's 43rd largest Biotechnology company by market cap, slipped further on Wednesday, sliding an additional 8.0c (8.2%) to trade at 89.0c. The stock tumbled 9.1% on Monday and 3.0% on Tuesday. This brought its 6-day fall to 44.0%, compared with the S&P/TSX 60 Index which fell 20.7 points (2.2%) in the six days for a relative price change of -41.8%. The fall was exacerbated by a cumulative 6-day volume of 13 times average

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 10 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox